Global Respiratory Care Devices Market (2010 - 2015)
The global respiratory care devices market has grown significantly over past few years and is expected to grow at a steady pace in the coming five years. Rapidly aging population, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), technical advances in respiratory care devices market and tight budget faced by healthcare institutions are the major factors influencing the market.
Positive airway pressure devices command the largest share in the respiratory care therapeutic devices segment. Technical advances such as portability, and increased battery life are primarily influencing the growth of this market.
Emergence of home healthcare has opened new avenues for the respiratory care devices market. Currently this segment accounts for about 40 % of the end user market. Convenience and comfort in a home care environment coupled with cost advantages are the major factors driving the home healthcare market for respiratory care devices.
U.S. accounts for the largest in the global respiratory care devices market. Demographic changes and rising incidence of COPD are among the major factors influencing the market. COPD is the fourth leading cause of death in the U.S.; about 12 million Americans suffer from COPD.
This research report categorizes the respiratory care devices market on the basis of diagnostic, therapeutic & monitoring devices, and preterm respiratory care, forecasting revenues and analyzing trends in each of the submarkets.
Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide market tables for covering the micro-markets along with more than 10 company profiles.
MARKETS COVERED
This research report categorizes the respiratory care devices market into the following:
Respiratory Care Diagnostic Devices (Mass Spectrometers, Plethysmograph, Exercise Testing Equipment, Recorders, Peak Flow Meters, Pneumotachometers, Capnographs, Gas Analyzers, Spirometers)
Respiratory Care Therapeutic Devices (Humidifiers, Nebulizers, Oxygen Concentrators, Positive Airway Pressure Devices, Reusable Resuscitators, Ventilators, Respiratory Inhalers)
Respiratory Care Monitoring Devices & respiratory Disposables (Respiratory Care Monitoring Devices -Ventilators for respiratory Care, Pulse Oximeters; Respiratory Disposables - Disposable Oxygen Masks, Resuscitators, Tracheostomy tubes, Oxygen Cannulae)
Preterm Respiratory Care Devices (Infant Ventilator, Nasal cannula, Oxygen hood, Endotracheal tube, Nasal CPAP, ECMO (Extracorporeal membrane oxygenation), Nitric oxide delivery unit, Resuscitation bags)
RESEARCH METHODOLOGY
Market information will be obtained through secondary research on company websites and news articles.
Market size of the segments will be calculated using the bottom-up approach.
Market revenues of key players will be determined by primary and secondary research, which includes study of the annual reports of the company and interviews with key opinion leaders, CEOs, directors and managers.
STAKEHOLDERS
Respiratory Care Device manufacturers
Respiratory Care device distributors
Healthcare institutions (Hospitals, laboratories, Medical schools, and governing bodies)
Various research and consulting companies
Various research associations related to Respiratory Care Device
Positive airway pressure devices command the largest share in the respiratory care therapeutic devices segment. Technical advances such as portability, and increased battery life are primarily influencing the growth of this market.
Emergence of home healthcare has opened new avenues for the respiratory care devices market. Currently this segment accounts for about 40 % of the end user market. Convenience and comfort in a home care environment coupled with cost advantages are the major factors driving the home healthcare market for respiratory care devices.
U.S. accounts for the largest in the global respiratory care devices market. Demographic changes and rising incidence of COPD are among the major factors influencing the market. COPD is the fourth leading cause of death in the U.S.; about 12 million Americans suffer from COPD.
This research report categorizes the respiratory care devices market on the basis of diagnostic, therapeutic & monitoring devices, and preterm respiratory care, forecasting revenues and analyzing trends in each of the submarkets.
Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide market tables for covering the micro-markets along with more than 10 company profiles.
MARKETS COVERED
This research report categorizes the respiratory care devices market into the following:
Respiratory Care Diagnostic Devices (Mass Spectrometers, Plethysmograph, Exercise Testing Equipment, Recorders, Peak Flow Meters, Pneumotachometers, Capnographs, Gas Analyzers, Spirometers)
Respiratory Care Therapeutic Devices (Humidifiers, Nebulizers, Oxygen Concentrators, Positive Airway Pressure Devices, Reusable Resuscitators, Ventilators, Respiratory Inhalers)
Respiratory Care Monitoring Devices & respiratory Disposables (Respiratory Care Monitoring Devices -Ventilators for respiratory Care, Pulse Oximeters; Respiratory Disposables - Disposable Oxygen Masks, Resuscitators, Tracheostomy tubes, Oxygen Cannulae)
Preterm Respiratory Care Devices (Infant Ventilator, Nasal cannula, Oxygen hood, Endotracheal tube, Nasal CPAP, ECMO (Extracorporeal membrane oxygenation), Nitric oxide delivery unit, Resuscitation bags)
RESEARCH METHODOLOGY
Market information will be obtained through secondary research on company websites and news articles.
Market size of the segments will be calculated using the bottom-up approach.
Market revenues of key players will be determined by primary and secondary research, which includes study of the annual reports of the company and interviews with key opinion leaders, CEOs, directors and managers.
STAKEHOLDERS
Respiratory Care Device manufacturers
Respiratory Care device distributors
Healthcare institutions (Hospitals, laboratories, Medical schools, and governing bodies)
Various research and consulting companies
Various research associations related to Respiratory Care Device
EXECUTIVE SUMMARY
MARKET SCENARIO
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
2 SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 DEFINITION OF RESPIRATORY CARE MARKET
3.3 EVOLUTION OF RESPIRATORY CARE MARKET
3.4 DRIVERS
3.4.1 HIGH PREVALENCE OF RESPIRATORY DISEASES
3.4.2 CHANGING LIFESTYLE & INCREASING NUMBER OF SMOKERS
3.4.3 GROWING NUMBER OF AGED PEOPLE
3.4.4 TECHNOLOGICAL ADVANCEMENTS
3.5 RESTRAINTS
3.5.1 ECONOMIC SLOWDOWN
3.6 KEY TRENDS
3.6.1 EMERGING ECONOMIES DEMAND COST-EFFICIENT EQUIPMENT
3.6.2 INCREASING FOCUS ON COMPACT DEVICES FOR DIAGNOSTICS
3.7 PAP DEVICES DOMINATE THERAPEUTICS AREA
3.8 CAPNOGRAPHY DEVICE AS POPULAR MONITORING EQUIPMENT
3.9 SPIROMETERS CONTINUE TO LEAD RESPIRATORY DIAGNOSTIC DEVICES MARKET
3.10 PATENT ANALYSIS
3.10.1 RESMED FOCUSING ON THE THERAPEUTICS SEGMENT
3.10.2 DEVICE MANUFACTURERS FOCUSING ON VENTILATORS & INHALERS SEGMENTS
4 RESPIRATORY CARE THERAPEUTICS DEVICES
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 HOME HEALTHCARE GROWTH LEADING TO INCREASED DEMAND FOR THERAPEUTIC DEVICES
4.2.2 USER-FRIENDLY SYSTEMS & TECHNOLOGY INCREASES ADOPTION OF DEVICES
4.3 RESTRAINTS
4.3.1 MARKET SATURATION
4.3.2 HIGH COST OF OWNERSHIP RESTRICTS THE ADOPTION OF DEVICES
4.4 OPPORTUNITIES
4.4.1 USED IN DELIVERY OF VACCINES, SYSTEMIC THERAPY & GENE-REPLACEMENT THERAPY
4.5 BURNING ISSUES
4.5.1 BAN ON CHLOROFLUOROCARBON BASED PROPELLANTS
4.5.2 REDUCTION IN THE REIMBURSEMENT AMOUNT FOR HOME OXYGEN
4.6 WINNING IMPERATIVES
4.6.1 LOWER OPERATING COSTS & PACKAGING GIVES LONG TERM ADVANTAGE
4.6.2 PORTABILITY IS A KEY DISTINGUISHING FEATURE
4.7 HUMIDIFIERS
4.7.1 HEATED HUMIDIFIERS
4.7.2 PASSOVER HUMIDIFIERS
4.8 FURTHER CLASSIFICATION OF HEATED & PASSOVER HUMIDIFIERS
4.8.1 INTEGRATED HUMIDIFIERS
4.8.2 BUILT-IN HUMIDIFIERS
4.8.3 STAND-ALONE HUMIDIFIERS
4.9 NEBULIZERS
4.9.1 COMPRESSOR-BASED NEBULIZERS
4.9.2 PISTON BASED HAND-HELD NEBULIZERS
4.9.3 ULTRASONIC NEBULIZERS
4.10 OXYGEN CONCENTRATORS
4.10.1 FIXED OXYGEN CONCENTRATORS
4.10.2 PORTABLE OXYGEN CONCENTRATORS
4.11 POSITIVE AIRWAY PRESSURE (PAP) DEVICES
4.11.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
4.11.2 OTHER PAP DEVICES
4.11.2.1 TBi-level PAP devices & automatic PAP devices
4.12 REUSABLE RESUSCITATORS
4.13 VENTILATORS
4.13.1 ADULT VENTILATORS
4.13.2 NEONATAL VENTILATORS
4.14 RESPIRATORY INHALERS
4.14.1 DRY POWDER INHALERS
4.14.2 METERED DOSE INHALERS
5 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES
5.1 INTRODUCTION
5.2 DRIVERS & RESTRAINTS
5.2.1 RISING FOCUS ON MONITORING RESPIRATORY DISEASES
5.2.2 HIGH LEVEL OF SATURATION IN PULSE OXIMETERS
5.3 BURNING ISSUES
5.3.1 WHO INITIATIIVE FOR DEVELOPING COST EFFECTIVE OXIMETERS
5.4 WINNING IMPERATIVES
5.4.1 FOCUS ON ADDITIONAL FEATURES TO GAIN COMPETITIVE EDGE
5.4.2 USP IS COMPACTNESS OF DEVICES
5.5 RESPIRATORY CARE MONITORING DEVICES
5.5.1 PULSE OXIMETER
5.5.1.1 Pulse oximeter equipment
5.5.1.1.1 Handheld pulse oximeters
5.5.1.1.2 Fingertip pulse oximeters
5.5.1.1.3 Tabletop pulse oximeters
5.5.1.1.4 Wrist worn pulse oximeters
5.5.1.2 Pulse oximeter sensors
5.5.2 CAPNOGRAPHS
5.5.3 GAS ANALYZERS
5.6 RESPIRATORY DISPOSABLES
5.6.1 DISPOSABLE OXYGEN MASK
5.6.2 DISPOSABLE RESUSCITATORS
5.6.3 TRACHEOSTOMY TUBES
5.6.4 OXYGEN CANNULAE
6 RESPIRATORY CARE DIAGNOSTIC DEVICES (RESPIRATORY MEASUREMENT DEVICES)
6.1 INTRODUCTION
6.2 DRIVERS & RESTRAINTS
6.2.1 DEVELOPING ECONOMIES PROVIDE A GROWING DIAGNOSTICS MARKET
6.2.2 COMPLICATED REIMBURSEMENT PROCESS IN DIAGNOSTICS SEGMENT
6.2.3 HIGHLY COMPETITIVE
6.3 OPPORTUNITIES
6.3.1 POINT-OF-CARE DIAGNOSTICS AN UPCOMING OPPORTUNITY
6.4 BURNING ISSUES & TRENDS
6.4.1 SPIROMETRY IN TODDLERS/INFANTS A CHALLENGE
6.4.2 SPIROMETER ON IPHONE
6.5 WINNING IMPERATIVES
6.5.1 FOCUS ON ACCURATE &CLINICALLY IMPORTANT IMFORMATION
6.6 SPIROMETER
6.6.1 MECHANICAL VOLUME SPIROMETERS
6.6.2 AUTOMATED FLOW SPIROMETERS
6.7 PEAK FLOW METERS
6.8 RECORDERS/ POLYSOMNOGRAPHY DEVICES
6.9 OTHER DIAGNOSTIC DEVICES
6.9.1 EXERCISE TESTING EQUIPMENT
6.9.2 PNEUMOTACHOMETERS
6.9.2.1 Fleisch type pneumotachometers
6.9.2.2 Lilly type pneumotachometers
6.9.3 PLETHYSMOGRAPHS
7 PRETERM RESPIRATORY CARE DEVICES
7.1 INTRODUCTION
7.2 DRIVERS
7.2.1 INCREASING INCIDENCE RATE OF PRETERM BIRTHS
7.2.2 LARGE NUMBER OF INFANTS SUFFERING FROM RESPIRATORY DISTRESS SYNDROME
7.3 RESTRAINTS
7.3.1 HIGH ENTRY BARRIERS
7.3.2 LOW COST VENTILATORS
7.4 OPPORTUNITY
7.4.1 MULTIFUNCTIONAL MEDICAL DEVICES
7.4.2 SOFTWARE SOLUTIONS A HIGH GROWTH OPPORTUNITY
7.5 BURNING ISSUES & TRENDS
7.5.1 HARMFUL EFFECTS OF CERTAIN DEVICES
7.5.2 INCREASING RESEARCH IN USE OF MICROPROCESSING TECHNOLOGY IN PRETERM DEVICES
7.6 WINNING IMPERATIVES
7.6.1 ROBUST DISTRIBUTION CHANNELS
7.6.2 FOCUS ON SPECIFIC FEATURES BY THE MARKET PLAYERS
7.7 INFANT VENTILATORS
7.8 OXYGEN HOODS
7.9 NASAL CPAPS
7.10 ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)
7.11 NITRIC OXIDE DELIVERY UNITS
7.12 RESUSCITATORS
8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 U.S.
8.3 EUROPE
8.4 ASIA
8.5 ROW
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 AGREEMENTS & PARTNERSHIPS/CONTRACTS/ALLIANCES
9.3 MERGERS/ACQUISITIONS/COLLABORATIONS
9.4 PRODUCT LAUNCH/PRODUCT INTEGRATION
9.5 OTHERS
10 COMPANY PROFILES
10.1 AIRSEP CORP
10.1.1 OVERVIEW
10.1.2 PRODUCTS & SERVICES
10.1.3 STRATEGY
10.2 ALLIED HEALTHCARE PRODUCTS
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS & SERVICES
10.2.4 STRATEGY
10.2.5 DEVELOPMENTS
10.3 CAREFUSION CORP
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS & SERVICES
10.3.4 STRATEGY
10.3.5 DEVELOPMENTS
10.4 COMPUMEDICS LTD
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS & SERVICES
10.4.4 STRATEGY
10.4.5 DEVELOPMENTS
10.5 COVIDIEN, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCTS & SERVICES
10.5.4 STRATEGY
10.5.5 DEVELOPMENTS
10.6 DEVILBISS HEALTHCARE
10.6.1 OVERVIEW
10.6.2 PRODUCTS & SERVICES
10.6.3 STRATEGY
10.6.4 DEVELOPMENTS
10.7 DRAGER MEDICAL GMBH
10.7.1 OVERVIEW
10.7.2 PRODUCTS & SERVICES
10.7.3 STRATEGY
10.7.4 DEVELOPMENTS
10.8 FISHER & PAYKEL
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCTS & SERVICES
10.8.4 STRATEGY
10.8.5 DEVELOPMENTS
10.9 GE HEALTHCARE
10.9.1 OVERVIEW
10.9.2 PRODUCTS & SERVICES
10.9.3 STRATEGY
10.9.4 DEVELOPMENTS
10.10 HAMILTON MEDICAL AG
10.10.1 OVERVIEW
10.10.2 PRODUCTS & SERVICES
10.10.3 STRATEGY
10.10.4 DEVELOPMENTS
10.11 INVACARE CORP
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCTS & SERVICES
10.11.4 STRATEGY
10.12 MAQUET GMBH
10.12.1 OVERVIEW
10.12.2 PRODUCTS & SERVICES
10.12.3 STRATEGY
10.12.4 DEVELOPMENTS
10.13 PHILIPS HEALTHCARE
10.13.1 OVERVIEW
10.13.2 PRODUCTS & SERVICES
10.13.3 STRATEGY
10.13.4 DEVELOPMENTS
10.14 RESMED, INC.
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.3 PRODUCTS & SERVICES
10.14.4 STRATEGY
10.14.5 DEVELOPMENTS
APPENDIX
U.S. PATENTS
EUROPE PATENTS
JAPAN PATENTS
MARKET SCENARIO
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
2 SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 DEFINITION OF RESPIRATORY CARE MARKET
3.3 EVOLUTION OF RESPIRATORY CARE MARKET
3.4 DRIVERS
3.4.1 HIGH PREVALENCE OF RESPIRATORY DISEASES
3.4.2 CHANGING LIFESTYLE & INCREASING NUMBER OF SMOKERS
3.4.3 GROWING NUMBER OF AGED PEOPLE
3.4.4 TECHNOLOGICAL ADVANCEMENTS
3.5 RESTRAINTS
3.5.1 ECONOMIC SLOWDOWN
3.6 KEY TRENDS
3.6.1 EMERGING ECONOMIES DEMAND COST-EFFICIENT EQUIPMENT
3.6.2 INCREASING FOCUS ON COMPACT DEVICES FOR DIAGNOSTICS
3.7 PAP DEVICES DOMINATE THERAPEUTICS AREA
3.8 CAPNOGRAPHY DEVICE AS POPULAR MONITORING EQUIPMENT
3.9 SPIROMETERS CONTINUE TO LEAD RESPIRATORY DIAGNOSTIC DEVICES MARKET
3.10 PATENT ANALYSIS
3.10.1 RESMED FOCUSING ON THE THERAPEUTICS SEGMENT
3.10.2 DEVICE MANUFACTURERS FOCUSING ON VENTILATORS & INHALERS SEGMENTS
4 RESPIRATORY CARE THERAPEUTICS DEVICES
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 HOME HEALTHCARE GROWTH LEADING TO INCREASED DEMAND FOR THERAPEUTIC DEVICES
4.2.2 USER-FRIENDLY SYSTEMS & TECHNOLOGY INCREASES ADOPTION OF DEVICES
4.3 RESTRAINTS
4.3.1 MARKET SATURATION
4.3.2 HIGH COST OF OWNERSHIP RESTRICTS THE ADOPTION OF DEVICES
4.4 OPPORTUNITIES
4.4.1 USED IN DELIVERY OF VACCINES, SYSTEMIC THERAPY & GENE-REPLACEMENT THERAPY
4.5 BURNING ISSUES
4.5.1 BAN ON CHLOROFLUOROCARBON BASED PROPELLANTS
4.5.2 REDUCTION IN THE REIMBURSEMENT AMOUNT FOR HOME OXYGEN
4.6 WINNING IMPERATIVES
4.6.1 LOWER OPERATING COSTS & PACKAGING GIVES LONG TERM ADVANTAGE
4.6.2 PORTABILITY IS A KEY DISTINGUISHING FEATURE
4.7 HUMIDIFIERS
4.7.1 HEATED HUMIDIFIERS
4.7.2 PASSOVER HUMIDIFIERS
4.8 FURTHER CLASSIFICATION OF HEATED & PASSOVER HUMIDIFIERS
4.8.1 INTEGRATED HUMIDIFIERS
4.8.2 BUILT-IN HUMIDIFIERS
4.8.3 STAND-ALONE HUMIDIFIERS
4.9 NEBULIZERS
4.9.1 COMPRESSOR-BASED NEBULIZERS
4.9.2 PISTON BASED HAND-HELD NEBULIZERS
4.9.3 ULTRASONIC NEBULIZERS
4.10 OXYGEN CONCENTRATORS
4.10.1 FIXED OXYGEN CONCENTRATORS
4.10.2 PORTABLE OXYGEN CONCENTRATORS
4.11 POSITIVE AIRWAY PRESSURE (PAP) DEVICES
4.11.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
4.11.2 OTHER PAP DEVICES
4.11.2.1 TBi-level PAP devices & automatic PAP devices
4.12 REUSABLE RESUSCITATORS
4.13 VENTILATORS
4.13.1 ADULT VENTILATORS
4.13.2 NEONATAL VENTILATORS
4.14 RESPIRATORY INHALERS
4.14.1 DRY POWDER INHALERS
4.14.2 METERED DOSE INHALERS
5 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES
5.1 INTRODUCTION
5.2 DRIVERS & RESTRAINTS
5.2.1 RISING FOCUS ON MONITORING RESPIRATORY DISEASES
5.2.2 HIGH LEVEL OF SATURATION IN PULSE OXIMETERS
5.3 BURNING ISSUES
5.3.1 WHO INITIATIIVE FOR DEVELOPING COST EFFECTIVE OXIMETERS
5.4 WINNING IMPERATIVES
5.4.1 FOCUS ON ADDITIONAL FEATURES TO GAIN COMPETITIVE EDGE
5.4.2 USP IS COMPACTNESS OF DEVICES
5.5 RESPIRATORY CARE MONITORING DEVICES
5.5.1 PULSE OXIMETER
5.5.1.1 Pulse oximeter equipment
5.5.1.1.1 Handheld pulse oximeters
5.5.1.1.2 Fingertip pulse oximeters
5.5.1.1.3 Tabletop pulse oximeters
5.5.1.1.4 Wrist worn pulse oximeters
5.5.1.2 Pulse oximeter sensors
5.5.2 CAPNOGRAPHS
5.5.3 GAS ANALYZERS
5.6 RESPIRATORY DISPOSABLES
5.6.1 DISPOSABLE OXYGEN MASK
5.6.2 DISPOSABLE RESUSCITATORS
5.6.3 TRACHEOSTOMY TUBES
5.6.4 OXYGEN CANNULAE
6 RESPIRATORY CARE DIAGNOSTIC DEVICES (RESPIRATORY MEASUREMENT DEVICES)
6.1 INTRODUCTION
6.2 DRIVERS & RESTRAINTS
6.2.1 DEVELOPING ECONOMIES PROVIDE A GROWING DIAGNOSTICS MARKET
6.2.2 COMPLICATED REIMBURSEMENT PROCESS IN DIAGNOSTICS SEGMENT
6.2.3 HIGHLY COMPETITIVE
6.3 OPPORTUNITIES
6.3.1 POINT-OF-CARE DIAGNOSTICS AN UPCOMING OPPORTUNITY
6.4 BURNING ISSUES & TRENDS
6.4.1 SPIROMETRY IN TODDLERS/INFANTS A CHALLENGE
6.4.2 SPIROMETER ON IPHONE
6.5 WINNING IMPERATIVES
6.5.1 FOCUS ON ACCURATE &CLINICALLY IMPORTANT IMFORMATION
6.6 SPIROMETER
6.6.1 MECHANICAL VOLUME SPIROMETERS
6.6.2 AUTOMATED FLOW SPIROMETERS
6.7 PEAK FLOW METERS
6.8 RECORDERS/ POLYSOMNOGRAPHY DEVICES
6.9 OTHER DIAGNOSTIC DEVICES
6.9.1 EXERCISE TESTING EQUIPMENT
6.9.2 PNEUMOTACHOMETERS
6.9.2.1 Fleisch type pneumotachometers
6.9.2.2 Lilly type pneumotachometers
6.9.3 PLETHYSMOGRAPHS
7 PRETERM RESPIRATORY CARE DEVICES
7.1 INTRODUCTION
7.2 DRIVERS
7.2.1 INCREASING INCIDENCE RATE OF PRETERM BIRTHS
7.2.2 LARGE NUMBER OF INFANTS SUFFERING FROM RESPIRATORY DISTRESS SYNDROME
7.3 RESTRAINTS
7.3.1 HIGH ENTRY BARRIERS
7.3.2 LOW COST VENTILATORS
7.4 OPPORTUNITY
7.4.1 MULTIFUNCTIONAL MEDICAL DEVICES
7.4.2 SOFTWARE SOLUTIONS A HIGH GROWTH OPPORTUNITY
7.5 BURNING ISSUES & TRENDS
7.5.1 HARMFUL EFFECTS OF CERTAIN DEVICES
7.5.2 INCREASING RESEARCH IN USE OF MICROPROCESSING TECHNOLOGY IN PRETERM DEVICES
7.6 WINNING IMPERATIVES
7.6.1 ROBUST DISTRIBUTION CHANNELS
7.6.2 FOCUS ON SPECIFIC FEATURES BY THE MARKET PLAYERS
7.7 INFANT VENTILATORS
7.8 OXYGEN HOODS
7.9 NASAL CPAPS
7.10 ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)
7.11 NITRIC OXIDE DELIVERY UNITS
7.12 RESUSCITATORS
8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 U.S.
8.3 EUROPE
8.4 ASIA
8.5 ROW
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 AGREEMENTS & PARTNERSHIPS/CONTRACTS/ALLIANCES
9.3 MERGERS/ACQUISITIONS/COLLABORATIONS
9.4 PRODUCT LAUNCH/PRODUCT INTEGRATION
9.5 OTHERS
10 COMPANY PROFILES
10.1 AIRSEP CORP
10.1.1 OVERVIEW
10.1.2 PRODUCTS & SERVICES
10.1.3 STRATEGY
10.2 ALLIED HEALTHCARE PRODUCTS
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCTS & SERVICES
10.2.4 STRATEGY
10.2.5 DEVELOPMENTS
10.3 CAREFUSION CORP
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCTS & SERVICES
10.3.4 STRATEGY
10.3.5 DEVELOPMENTS
10.4 COMPUMEDICS LTD
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCTS & SERVICES
10.4.4 STRATEGY
10.4.5 DEVELOPMENTS
10.5 COVIDIEN, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCTS & SERVICES
10.5.4 STRATEGY
10.5.5 DEVELOPMENTS
10.6 DEVILBISS HEALTHCARE
10.6.1 OVERVIEW
10.6.2 PRODUCTS & SERVICES
10.6.3 STRATEGY
10.6.4 DEVELOPMENTS
10.7 DRAGER MEDICAL GMBH
10.7.1 OVERVIEW
10.7.2 PRODUCTS & SERVICES
10.7.3 STRATEGY
10.7.4 DEVELOPMENTS
10.8 FISHER & PAYKEL
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCTS & SERVICES
10.8.4 STRATEGY
10.8.5 DEVELOPMENTS
10.9 GE HEALTHCARE
10.9.1 OVERVIEW
10.9.2 PRODUCTS & SERVICES
10.9.3 STRATEGY
10.9.4 DEVELOPMENTS
10.10 HAMILTON MEDICAL AG
10.10.1 OVERVIEW
10.10.2 PRODUCTS & SERVICES
10.10.3 STRATEGY
10.10.4 DEVELOPMENTS
10.11 INVACARE CORP
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCTS & SERVICES
10.11.4 STRATEGY
10.12 MAQUET GMBH
10.12.1 OVERVIEW
10.12.2 PRODUCTS & SERVICES
10.12.3 STRATEGY
10.12.4 DEVELOPMENTS
10.13 PHILIPS HEALTHCARE
10.13.1 OVERVIEW
10.13.2 PRODUCTS & SERVICES
10.13.3 STRATEGY
10.13.4 DEVELOPMENTS
10.14 RESMED, INC.
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.3 PRODUCTS & SERVICES
10.14.4 STRATEGY
10.14.5 DEVELOPMENTS
APPENDIX
U.S. PATENTS
EUROPE PATENTS
JAPAN PATENTS
LIST OF TABLES
TABLE 1 GLOBAL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 2 GLOBAL RESPIRATORY CARE THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 3 GLOBAL RESPIRATORY CARE THERAPEUTIC DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 4 RESPIRATORY CARE THERAPEUTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 5 GLOBAL HUMIDIFIERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 6 GLOBAL HUMIDIFIERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 7 HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 8 HEATED HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 9 PASSOVER HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 10 NEBULIZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 11 GLOBAL OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 12 GLOBAL OXYGEN CONCENTRATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 13 OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 14 FIXED OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 15 PORTABLE OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 16 GLOBAL PAP DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 17 PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 18 CPAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 19 OTHER PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 20 REUSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 21 GLOBAL VENTILATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 22 GLOBAL VENTILATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 23 VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 24 ADULT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 25 NEONATAL VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TBLE 26 GLOBAL RESPIRATORY INHALERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 27 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 28 RESPIRATORY INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 29 DRY POWDER INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 30 METERED DOSE INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 31 GLOBAL RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 32 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 33 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 34 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 35 RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36 GLOBAL PULSE OXIMETRY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 37 PULSE OXIMETRY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 38 PULSE OXIMETERS EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 39 PULSE OXIMETER SENSORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 40 CAPNOGRAPHS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 41 GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 42 GLOBAL RESPIRATORY DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 43 GLOBAL RESPIRATORY DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 44 RESPIRATORY DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 45 DISPOSABLES OXYGEN MASK MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 46 DISPOSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 47 TRACHEOSTOMY TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 48 OXYGEN CANNULAE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 49 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 50 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 51 RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 52 SPIROMETERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 53 PEAK FLOW METERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 54 POLYSOMNOGRAPHY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 55 OTHER DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 56 GLOBAL PRETERM RESPIRATORY CARE DEVICE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($THOUSANDS)
TABLE 57 PRETERM RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 58 INFANT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 59 OXYGEN HOOD MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 60 NASAL CPAP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 61 ECMO MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 62 NITRIC OXIDE DELIVERY UNIT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 63 INFANT RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 64 RESPIRATORY CARE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 65 U.S. RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 66 EUROPE RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 67 ASIA RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 68 ROW RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 69 AGREEMENTS & PARTNERSHIPS, CONTRACTS, ALLIANCES (2008 – 2010)
TABLE 70 MERGERS, ACQUISITIONS, COLLABORATIONS (2008 – 2011)
TABLE 71 NEW PRODUCTS, TECHNOLOGIES, SERVICES LAUNCHED (2009 – 2011)
TABLE 72 OTHER DEVELOPMENTS IN THE RESPIRATORY CARE MARKET (2008 – 2011)
TABLE 73 ALLIED HEALTHCARE PRODUCTS REVENUE & R&D EXPENSES ($MILLION)
TABLE 74 ALLIED HEALTHCARE PRODUCTS SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 75 ALLIED HEALTHCARE PRODUCTS SALES BY REGION ($MILLION)
TABLE 76 CAREFUSION CORPORATION REVENUE & R&D EXPENSES ($MILLION)
TABLE 77 CAREFUSION CORPORATION SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 78 CAREFUSION CORPORATION SALES BY REGION ($MILLION)
TABLE 79 COMPUMEDICS LIMITED SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 80 COMPUMEDICS LIMITED SALES BY REGION ($MILLION)
TABLE 81 COVIDIEN, INC. REVENUE AND R&D EXPENSES ($MILLION)
TABLE 82 COVIDIEN, INC. SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 83 COVIDIEN, INC. SALES BY REGION ($MILLION)
TABLE 84 FISHER & PAYKEL REVENUE AND R&D EXPENSES ($MILLION)
TABLE 85 FISHER & PAYKEL SALES BY REGION ($MILLION)
TABLE 86 INVACARE CORP REVENUE AND R&D EXPENSES ($MILLION)
TABLE 87 INVACARE CORP SALES BY REGION ($MILLION)
TABLE 88 RESMED, INC. REVENUE & R&D EXPENSES ($MILLION)
TABLE 89 RESMED, INC SALES BY REGION ($MILLION)
TABLE 1 GLOBAL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 2 GLOBAL RESPIRATORY CARE THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 3 GLOBAL RESPIRATORY CARE THERAPEUTIC DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 4 RESPIRATORY CARE THERAPEUTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 5 GLOBAL HUMIDIFIERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 6 GLOBAL HUMIDIFIERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 7 HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 8 HEATED HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 9 PASSOVER HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 10 NEBULIZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 11 GLOBAL OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 12 GLOBAL OXYGEN CONCENTRATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 13 OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 14 FIXED OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 15 PORTABLE OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 16 GLOBAL PAP DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 17 PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 18 CPAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 19 OTHER PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 20 REUSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 21 GLOBAL VENTILATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 22 GLOBAL VENTILATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 23 VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 24 ADULT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 25 NEONATAL VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TBLE 26 GLOBAL RESPIRATORY INHALERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 27 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 28 RESPIRATORY INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 29 DRY POWDER INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 30 METERED DOSE INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 31 GLOBAL RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 32 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 33 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 34 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 35 RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36 GLOBAL PULSE OXIMETRY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 37 PULSE OXIMETRY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 38 PULSE OXIMETERS EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 39 PULSE OXIMETER SENSORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 40 CAPNOGRAPHS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 41 GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 42 GLOBAL RESPIRATORY DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 43 GLOBAL RESPIRATORY DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 44 RESPIRATORY DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 45 DISPOSABLES OXYGEN MASK MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 46 DISPOSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 47 TRACHEOSTOMY TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 48 OXYGEN CANNULAE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 49 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 50 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 51 RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 52 SPIROMETERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 53 PEAK FLOW METERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 54 POLYSOMNOGRAPHY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 55 OTHER DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 56 GLOBAL PRETERM RESPIRATORY CARE DEVICE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($THOUSANDS)
TABLE 57 PRETERM RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 58 INFANT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 59 OXYGEN HOOD MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 60 NASAL CPAP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 61 ECMO MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 62 NITRIC OXIDE DELIVERY UNIT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 63 INFANT RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSANDS)
TABLE 64 RESPIRATORY CARE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 65 U.S. RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 66 EUROPE RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 67 ASIA RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 68 ROW RESPIRATORY CARE MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 69 AGREEMENTS & PARTNERSHIPS, CONTRACTS, ALLIANCES (2008 – 2010)
TABLE 70 MERGERS, ACQUISITIONS, COLLABORATIONS (2008 – 2011)
TABLE 71 NEW PRODUCTS, TECHNOLOGIES, SERVICES LAUNCHED (2009 – 2011)
TABLE 72 OTHER DEVELOPMENTS IN THE RESPIRATORY CARE MARKET (2008 – 2011)
TABLE 73 ALLIED HEALTHCARE PRODUCTS REVENUE & R&D EXPENSES ($MILLION)
TABLE 74 ALLIED HEALTHCARE PRODUCTS SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 75 ALLIED HEALTHCARE PRODUCTS SALES BY REGION ($MILLION)
TABLE 76 CAREFUSION CORPORATION REVENUE & R&D EXPENSES ($MILLION)
TABLE 77 CAREFUSION CORPORATION SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 78 CAREFUSION CORPORATION SALES BY REGION ($MILLION)
TABLE 79 COMPUMEDICS LIMITED SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 80 COMPUMEDICS LIMITED SALES BY REGION ($MILLION)
TABLE 81 COVIDIEN, INC. REVENUE AND R&D EXPENSES ($MILLION)
TABLE 82 COVIDIEN, INC. SALES BY BUSINESS SEGMENTS ($MILLION)
TABLE 83 COVIDIEN, INC. SALES BY REGION ($MILLION)
TABLE 84 FISHER & PAYKEL REVENUE AND R&D EXPENSES ($MILLION)
TABLE 85 FISHER & PAYKEL SALES BY REGION ($MILLION)
TABLE 86 INVACARE CORP REVENUE AND R&D EXPENSES ($MILLION)
TABLE 87 INVACARE CORP SALES BY REGION ($MILLION)
TABLE 88 RESMED, INC. REVENUE & R&D EXPENSES ($MILLION)
TABLE 89 RESMED, INC SALES BY REGION ($MILLION)
LIST OF FIGURES
FIGURE 1 SEGMENT WISE MARKET SHARE OF RESPIRATORY CARE DEVICES
FIGURE 2 GLOBAL RESPIRATORY CARE DEVICES MARKET BY SEGMENTS
FIGURE 3 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
FIGURE 4 CHANGE IN TECHNOLOGY IN THERAPEUTICS, DIAGNOSTICS, & MONITORING DEVICES
FIGURE 5 SEGMENT ANALYSIS (RESPIRATORY THERAPEUTICS DEVICES)
FIGURE 6 SEGMENT ANALYSIS (RESPIRATORY MONITORING DEVICES)
FIGURE 7 SEGMENT ANALYSIS (RESPIRATORY DIAGNOSTIC DEVICES)
FIGURE 8 PATENTS BY MARKET PLAYERS (2005- MARCH 2011)
FIGURE 9 PATENTS BY SEGMENTS (2005- MARCH 2011)
FIGURE 10 MARKET SHARE FOR FIXED OXYGEN CONCENTRATORS
FIGURE 11 MARKET SHARE FOR PORTABLE OXYGEN CONCENTRATORS
FIGURE 12 MARKET SHARE FOR PULSE OXIMETER
FIGURE 13 MAJOR STRATEGIC FOCUS BY MARKET PLAYERS
FIGURE 14 MAJOR PLAYERS USING DIFFERENT STRATEGIES TO GROW
FIGURE 1 SEGMENT WISE MARKET SHARE OF RESPIRATORY CARE DEVICES
FIGURE 2 GLOBAL RESPIRATORY CARE DEVICES MARKET BY SEGMENTS
FIGURE 3 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
FIGURE 4 CHANGE IN TECHNOLOGY IN THERAPEUTICS, DIAGNOSTICS, & MONITORING DEVICES
FIGURE 5 SEGMENT ANALYSIS (RESPIRATORY THERAPEUTICS DEVICES)
FIGURE 6 SEGMENT ANALYSIS (RESPIRATORY MONITORING DEVICES)
FIGURE 7 SEGMENT ANALYSIS (RESPIRATORY DIAGNOSTIC DEVICES)
FIGURE 8 PATENTS BY MARKET PLAYERS (2005- MARCH 2011)
FIGURE 9 PATENTS BY SEGMENTS (2005- MARCH 2011)
FIGURE 10 MARKET SHARE FOR FIXED OXYGEN CONCENTRATORS
FIGURE 11 MARKET SHARE FOR PORTABLE OXYGEN CONCENTRATORS
FIGURE 12 MARKET SHARE FOR PULSE OXIMETER
FIGURE 13 MAJOR STRATEGIC FOCUS BY MARKET PLAYERS
FIGURE 14 MAJOR PLAYERS USING DIFFERENT STRATEGIES TO GROW
